Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FOLOTYN® safely and effectively. See full prescribing information for FOLOTYN. FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
FOLOTYN is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is approved under accelerated approval based on overall response rate [see Clinical Studies (14)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
- generic_name
- pralatrexate
- product_names
- pralatrexate
- ndc
- 72893-003, 72893-005, 72893-003-01, 72893-005-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en